Atlas Invest | $25,000,000 | (Jan 22, 2026)
AiStrike | $7,000,000 | (Jan 22, 2026)
Zarminali Pediatrics | $110,000,000 | (Jan 22, 2026)
Kardome
Israel
- Tel Aviv
- 12/11/2024
- Series A
- $10,000,000
Kardome’s patented Spatial Hearing technology simultaneously enhances speech signals from multiple speakers in real time, isolating the target speech with unsurpassed accuracy and enabling users to achieve high-quality results.
Kardome knows who is talking, where they're located, and what they're saying.
Kardome was established in 2019 by a team of enthusiastic and passionate researchers with vast experience in algorithms and acoustics. We are motivated and dedicated to making voice-controlled devices usable in all environments.
Visit our Website Kardome.com to learn more or contact us at Info@kardome.com
- Industry Software Development
- Website https://www.kardome.com/
- LinkedIn https://www.linkedin.com/company/kardome/
Related People
Dani CherkasskyFounder
Israel -
Mazor, Center District
We founded Kardome to change the way people interact with machines and explore the true potential of speech recognition. Our goal is to provide a solution to end user frustrations with speech recognition and voice command devices.
Voice user interface technology has the immense potential to open a doorway to a new age in the way humans interact with machines. Today, voice-enabled devices make their way into every imaginable environment, from homes and offices to family cars, malls, and airports. The acoustic complexity of many of these environments creates a demand for improved speech recognition performance. Kardome is committed to enabling the fundamental shift toward voice-based interaction by upholding the Number 1 Rule of Speech Recognition: Listen to the User, Not the Background Noise.
One to One Health | $12,000,000 | (Jan 22, 2026)
AnswersNow | $40,000,000 | (Jan 22, 2026)
Claim Health | $4,400,000 | (Jan 22, 2026)
Upscale AI(US) | $200,000,000 | (Jan 22, 2026)
Nasdaq Private Market | $37,600,000 | (Jan 22, 2026)
PraxisPro | $6,000,000 | (Jan 22, 2026)
furl | $10,000,000 | (Jan 22, 2026)
humans& | $480,000,000 | (Jan 22, 2026)
Think Bioscience | $55,000,000 | (Jan 21, 2026)